Advantage plans do a better job than standalone Part D policies, albeit with important gap ...

The Protecting Patient Access to Cancer and Complex Therapies Act — PACTA — is critical to NJ patients who need access to infusion therapies.

Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis no longer have to travel long distances for specialized care.

Therapeutic drug monitoring would seem like an obvious match with rheumatology. Patients with clinically challenging ...

A 55-year-old man developed painful swelling that doctors later thought was arthritis. Subtle clues revealed something more ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 17 scientific posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting (March 27-31, Denver, ...

Sun Pharmaceutical Industries Limited. Sun Pharma announces US FDA acceptance of supplemental Biologics License Application for ILUMYA (tildrakizumab-asmn) for the treatment of adults with active ...

Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

Discover the Hidden Benefits of Guava Leaves You might have heard the saying, 'The fruit is as good as the seeds,' and this can certainly be applied to guavas. While guavas themselves are beneficial, ...

Recently published Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment ...

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...

Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aims to harness, direct and optimize their immune suppressive properties to address serious ...